Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Levamisol hydrochloride

EU orphan designation number: EU/3/05/324   
Active ingredient: Levamisol hydrochloride
Indication: Treatment of nephrotic syndrome
Sponsor: Addmedica SAS
84 rue d'Amsterdam, F-75009 Paris, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/11/2005 Centralised Orphan - Designation EMEA/OD/058/05 (2005)4342 of 28/10/2005